# Nasdaq:TVRD news releases

Nasdaq:TVRD press releases distributed through HARO Newswire to the journalists who cover the beat.

- **Releases in the last 90 days:** 391
- **Web page:** https://www.helpareporter.com/news-releases/nasdaqtvrd
- **RSS:** https://www.helpareporter.com/news-releases/nasdaqtvrd/rss.xml

### [Tvardi Therapeutics Advances Next-Generation Oral STAT3 Inhibitor TTI-109 Toward IND in Inflammatory Bowel Disease Following FDA Pre-IND Feedback](https://www.helpareporter.com/news-releases/tvardi-therapeutics-advances-next-generation-oral-stat3-inhibitor-tti)

November 19, 2026 · Tvardi Therapeutics · Nasdaq:TVRD

New analysis of Phase 1 exposure data supports the potential for sustained STAT3 inhibition at proposed clinical doses, with minimal predicted effect on STAT1 and STAT5 HOUSTON, Nov. 19, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc.
